Sumitomo Life Insurance Co. Sells 529 Shares of Exelon Co. (NASDAQ:EXC)

Sumitomo Life Insurance Co. trimmed its position in shares of Exelon Co. (NASDAQ:EXCFree Report) by 3.7% during the 4th quarter, Holdings Channel reports. The firm owned 13,687 shares of the company’s stock after selling 529 shares during the period. Sumitomo Life Insurance Co.’s holdings in Exelon were worth $515,000 at the end of the most recent reporting period.

A number of other large investors also recently modified their holdings of EXC. JPMorgan Chase & Co. boosted its holdings in shares of Exelon by 109.0% during the 3rd quarter. JPMorgan Chase & Co. now owns 5,884,282 shares of the company’s stock valued at $238,608,000 after purchasing an additional 3,068,309 shares during the last quarter. State Street Corp lifted its position in shares of Exelon by 3.7% in the third quarter. State Street Corp now owns 60,169,219 shares of the company’s stock worth $2,439,862,000 after buying an additional 2,156,259 shares in the last quarter. Nordea Investment Management AB boosted its stake in Exelon by 418.1% during the fourth quarter. Nordea Investment Management AB now owns 2,501,392 shares of the company’s stock valued at $94,152,000 after buying an additional 2,018,604 shares during the last quarter. FMR LLC grew its holdings in Exelon by 18.7% during the 3rd quarter. FMR LLC now owns 11,782,549 shares of the company’s stock valued at $477,782,000 after buying an additional 1,858,502 shares in the last quarter. Finally, Assenagon Asset Management S.A. increased its stake in Exelon by 212.2% in the 4th quarter. Assenagon Asset Management S.A. now owns 1,903,482 shares of the company’s stock worth $71,647,000 after acquiring an additional 1,293,753 shares during the last quarter. Hedge funds and other institutional investors own 80.92% of the company’s stock.

Exelon Price Performance

Shares of EXC stock opened at $40.02 on Friday. The stock has a 50 day moving average price of $38.18 and a 200 day moving average price of $38.49. Exelon Co. has a 52-week low of $33.35 and a 52-week high of $41.19. The company has a debt-to-equity ratio of 1.66, a quick ratio of 0.97 and a current ratio of 1.09. The firm has a market capitalization of $40.21 billion, a P/E ratio of 16.47, a P/E/G ratio of 2.61 and a beta of 0.55.

Exelon (NASDAQ:EXCGet Free Report) last released its earnings results on Wednesday, October 30th. The company reported $0.71 earnings per share for the quarter, topping the consensus estimate of $0.67 by $0.04. The business had revenue of $6.15 billion during the quarter, compared to the consensus estimate of $5.85 billion. Exelon had a return on equity of 9.47% and a net margin of 10.60%. The business’s revenue for the quarter was up 2.9% compared to the same quarter last year. During the same period last year, the company earned $0.67 earnings per share. As a group, sell-side analysts predict that Exelon Co. will post 2.46 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of research analysts recently weighed in on the stock. Scotiabank raised their target price on shares of Exelon from $40.00 to $42.00 and gave the company a “sector perform” rating in a report on Thursday, December 12th. Morgan Stanley dropped their price objective on shares of Exelon from $46.00 to $44.00 and set an “equal weight” rating for the company in a research note on Friday, November 22nd. Guggenheim upgraded shares of Exelon from a “neutral” rating to a “buy” rating in a research report on Thursday, January 23rd. Evercore ISI upgraded Exelon from an “in-line” rating to an “outperform” rating and lifted their price target for the stock from $43.00 to $44.00 in a research report on Tuesday, January 21st. Finally, Barclays decreased their price objective on Exelon from $44.00 to $42.00 and set an “overweight” rating on the stock in a research report on Wednesday, January 22nd. Five research analysts have rated the stock with a hold rating and five have issued a buy rating to the company. Based on data from MarketBeat, Exelon currently has a consensus rating of “Moderate Buy” and a consensus price target of $43.13.

View Our Latest Research Report on EXC

About Exelon

(Free Report)

Exelon Corporation, a utility services holding company, engages in the energy distribution and transmission businesses in the United States and Canada. The company is involved in the purchase and regulated retail sale of electricity and natural gas, transmission and distribution of electricity, and distribution of natural gas to retail customers.

See Also

Want to see what other hedge funds are holding EXC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Exelon Co. (NASDAQ:EXCFree Report).

Institutional Ownership by Quarter for Exelon (NASDAQ:EXC)

Receive News & Ratings for Exelon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exelon and related companies with MarketBeat.com's FREE daily email newsletter.